Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders

Journal of Acquired Immune Deficiency Syndromes

Volumn 47, Issue 4, 2008, Pages 449-458

  Weaver, Marcia R ^a,f   Conover, Christopher J ^b   Proescholdbell, Rae Jean ^c   Arno, Peter S ^d   Ang, Alfonso ^e   Ettner, Susan L ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b DUKE UNIVERSITY   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NONE   (United States)

Author keywords

Alcohol related disorders; Dual diagnoses; HIV infections; Mental health services utilization; Substance related disorders

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; ETHNICITY; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL HEALTH; PATIENT CARE; PRIORITY JOURNAL; SUBSTANCE ABUSE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; INSURANCE; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; MIDDLE AGED; MODELS, THEORETICAL; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 40549090888     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181642244     Document Type: Article

References (46)

1. Tucker JS, Burnam MA, Sherbourne CD, et al. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with Human Immunodeficiency Virus. Am J Med. 2003;114:573-580.
2. Ingersoll K. The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care. 2004;16:199-211.
3. Sherbourne CD, Hays RD, Fleishman JA, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248-254.
4. Kelly JA, Murphy DA, Bahr GR, et al. Factors associated with severity of depression and high-risk sexual behavior among persons diagnosed with Human Immunodeficiency Virus infection. Health Psychol. 1993;12:215-219.
5. Uldall K, Palmer NB, Whetten K, et al. Adherence in people living with HIV/AIDS, mental illness and chemical dependency: a review of the literature. AIDS Care. 2004;16(Suppl 1):S71-S96.
6. Douaihy AB, Jou RJ, Gorske T, et al. Triple diagnosis: dual diagnosis and HIV disease, part 2. AIDS Read. 2003;13:375-382.
7. Galvan FH, Burnam MA, Bing EG. Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. J Psychoactive Drugs. 2003;35(SARC Supplement 1):153-160.
8. Whetten K, Reif SS, Napravnik S, et al. Substance abuse and symptoms of mental illness among HIV-positive persons in the Southeast. South Med J. 2005;98:9-14.
9. Pence BW, Miller WC, Whetten K, et al. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders at an HIV clinic in the southeastern United States. J Acquir Immune Defic Syndr. 2006;42:298-306.
10. Lyketsos CG, Hanson A, Fishman M, et al. Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence. Int J Psychiatry Med. 1994;24:103-113.
11. Douaihy AB, Jou RJ, Gorske T, et al. Triple diagnosis: dual diagnosis and HIV disease, part I. AIDS Read. 2003;13:331-341.
12. Acuff C, Archambeault J, Greenberg B, et al. Mental health care for people living with or affected by HIV/AIDS: a practical guide. United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, National Mental Health Information Center. Available at: http://mentalhealth.samhsa.gov/publications/allpubs/KEN00-0081/default.asp. Accessed March 30, 2007.
13. Goldstein RB, Rotheram-Borus MJ, Johnson MO, et al. Insurance coverage, usual source of care, and receipt of clinically indicated care for comorbid conditions among adults living with HIV. Med Care. 2005;43:401-410.
14. Burnam MA, Bing EG, Morton SC, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001;58:729-736.
15. Vitiello B, Gurnam MA, Bing EG, et al. Use of psychotropic medications among HIV-infected patients in the United States. Am J Psychiatry. 2003;160:547-554.
16. Sambamoorthi U, Walkup J, Olfson M, et al. Antidepressant treatment and health services utilization among HIV-infected Medicaid patients diagnosed with depression. J Gen Intern Med. 2000;15:311-320.
17. US Department of Health and Human Services. Mental Health: Culture, Race, and Ethnicity - A Supplement to Mental Health: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services; 2001.
18. Robins L, Regier DA. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York: The Free Press; 1991.
19. Swartz MS, Wagner MR, Swanson JW, et al. Comparing use of private and public mental health services: the enduring barriers of race and age. Community Ment Health J. 1998;34:133-144.
20. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Smedley BD, Stith AY, Nelson AR, eds. Washington, DC: The National Academies Press; 2003.
21. Schmidt L, Greenfield T, Mulia N. Unequal treatment: racial and ethnic disparities in alcoholism treatment services. Alcohol Res Health. 2006;29:49-54.
22. Centers for Disease Control and Prevention. HIV/AIDS - United States, 1981-2000. MMWR Morb Mort Wkly Rep. 2001;50:430-434.
23. Centers for Disease Control and Prevention. HIV/AIDS factsheet: a glance at the HIV epidemic. Atlanta, GA: Centers for Disease Control and Prevention, April 2006. Available at: http://www.cdc.gov/hiv/resources/factsheets/At-A- Glance.htm. Accessed October 16, 2006.
24. Battacharya J, Goldman D, Sood N. The link between public and private insurance and HIV-related mortality. J Health Econ. 2003;22:1105-1122.
25. Smith SR, Kirking DM. The effect of insurance coverage changes on drug utilization in HIV disease. J Acquir Immune Defic Syndr. 2001;28:140-149.
26. Sturm R, Sherbourne CD. Are barriers to mental health and substance abuse care still rising? J Behav Health Serv Res. 2001;28:81-88.
27. Wells KB, Sherbourne CD, Sturm R, et al. Alcohol, drug abuse, and mental health care for uninsured and insured adults. Health Serv Res. 2002;37:1055-1066.
28. The HIV/AIDS Treatment Adherence, Health Outcomes, and Cost Study Group. Integrated services for people living with HIV/AIDS, mental health, and substance abuse disorders: the HIV/AIDS Treatment Adherence, Health Outcomes, and Cost Study. AIDS Care. 2004;(Suppl 1):S6-S21.
29. First MB, Spitzer RL, Williams JBW, et al. Structured Clinical Interview for DSM-IV (SCID). Washington, DC: American Psychiatric Association; 1995.
30. Palmer NB, Salcedo J, Miller AL, et al. Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population. AIDS Patient Care STDS. 2003;17:635-644.
31. Rabeneck L, Menke T, Wray NP. How good are U.S. studies of HIV costs of care? Med Care. 1999;37:748-759.
32. Ware JE, Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36), I; conceptual framework and item selection. Med Care. 1992;30:473-483.
33. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: Wiley; 1987.
34. Schafer JL. Analysis of Incomplete Multivariate Data. New York, NY: Chapman & Hall; 1997.
35. Hausman J. Specification tests in econometrics. Econometrica. 1978;46:1251-1271.
36. Deleted in proof.
37. Mooney CZ, Duval RD. Bootstrapping: A Nonparametric Approach to Statistical Inference. Thousand Oaks, CA: Sage Publications; 1993.
38. Duan N, Manning WG Jr, Morris CN, et al. A comparison of alternate models for the demand for medical care. J Bus Econ Stat. 1983;1:115-126.
39. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ. 1998;17:283-295.
40. Humphreys K, Mavis B, Stofflemayr B. Factors predicting attendance at self-help groups after substance abuse treatment: preliminary findings. J Consult Clin Psychol. 1991;59:591-593.
41. Theriot M, Segal S, Cowsert M. African Americans and comprehensive service use. Community Ment Health J. 2003;39:225-237.
42. Humphreys K, Moos R. Reduced substance-abuse-related health care costs among voluntary participants in Alcoholic Anonymous. Psychiatr Serv. 1996;47:709-713.
43. Soto TA, Bell J, Pillen MB, et al. Literature on integrated HIV care: a review. AIDS Care. 2005;16(Suppl 1):S43-S55.
44. Klinkenberg WD, Sacks S. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care. 2004;16(Suppl 1):S22-S42.
45. Ashman JJ, Conviser R, Pounds MB. Associations between HIV-positive individuals' receipt of ancillary services and medical care receipt and retention. AIDS Care. 2002;14(Suppl 1):S109-S118.
46. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Utilization Study. JAMA. 1999;281:2305-2315.